Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.810 USD | -2.02% | -0.51% | -14.43% |
11-15 | Harte Hanks, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 | CI |
11-14 | Earnings Flash (HHS) HARTE HANKS Posts Q3 Revenue $47.6M | MT |
Capitalization | 43.22M 40.86M 37.9M 33.8M 61.04M 3.67B 66.88M 471M 174M 1.5B 162M 159M 6.53B | P/E ratio 2022 |
2.46x | P/E ratio 2023 | -31.6x |
---|---|---|---|---|---|
Enterprise value | 53.37M 50.44M 46.79M 41.73M 75.37M 4.53B 82.57M 582M 215M 1.86B 200M 196M 8.06B | EV / Sales 2022 |
0.47x | EV / Sales 2023 | 0.31x |
Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
Last Transcript: Harte Hanks, Inc.
1 day | -2.02% | ||
1 week | -0.51% | ||
Current month | -0.51% | ||
1 month | -16.76% | ||
3 months | -20.74% | ||
6 months | -20.74% | ||
Current year | -14.43% |
Director | Title | Age | Since |
---|---|---|---|
Kirk Davis
CEO | Chief Executive Officer | 62 | 2023-06-18 |
David Garrison
DFI | Director of Finance/CFO | 55 | 2023-10-22 |
Elliott Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 2021-10-25 |
Manager | Title | Age | Since |
---|---|---|---|
John Griffin
CHM | Chairman | 63 | 2021-04-05 |
Bradley Radoff
BRD | Director/Board Member | 50 | 2021-05-16 |
Genevieve Combes
BRD | Director/Board Member | 57 | 2021-05-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 293,477 M€ | +35.85% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-2.02% | -0.51% | -17.24% | -28.27% | 43.22M | ||
+0.21% | +11.07% | +59.49% | +65.79% | 2.97B | ||
+0.90% | +1.20% | +166.88% | +73.97% | 1.51B | ||
-0.99% | -7.34% | +29.75% | - | 439M | ||
+90.00% | -1.83% | -47.49% | -53.55% | 356M | ||
+3.09% | +12.84% | -31.56% | -42.01% | 138M | ||
+0.62% | +2.88% | +20.26% | +7.95% | 128M | ||
-1.10% | +8.45% | +63.77% | - | 122M | ||
+0.47% | +1.55% | -1.62% | -42.37% | 57.15M | ||
Average | +10.13% | +4.40% | +26.92% | -2.64% | 640.79M | |
Weighted average by Cap. | +5.87% | +7.61% | +74.67% | +53.78% |
2022 | 2023 | |
---|---|---|
Net sales | 206M 195M 181M 161M 291M 17.5B 319M 2.25B 830M 7.18B 775M 758M 31.15B | 191M 181M 168M 150M 270M 16.25B 296M 2.09B 771M 6.67B 719M 703M 28.92B |
Net income | 36.78M 34.76M 32.25M 28.76M 51.94M 3.12B 56.9M 401M 148M 1.28B 138M 135M 5.55B | -1.57M -1.48M -1.38M -1.23M -2.22M -133M -2.43M -17.11M -6.32M -54.66M -5.9M -5.77M -237M |
Net Debt | 11.96M 11.3M 10.49M 9.35M 16.89M 1.01B 18.5M 130M 48.12M 416M 44.91M 43.93M 1.81B | 10.14M 9.59M 8.89M 7.93M 14.32M 861M 15.69M 111M 40.81M 353M 38.09M 37.25M 1.53B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-09 | 5.810 $ | -2.02% | 28,188 |
24-12-06 | 5.930 $ | +0.68% | 32,500 |
24-12-05 | 5.890 $ | +2.08% | 48,630 |
24-12-04 | 5.770 $ | +6.85% | 63,448 |
24-12-03 | 5.400 $ | -2.88% | 35,858 |
Delayed Quote Nasdaq, December 09, 2024 at 04:00 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- HHS Stock
MarketScreener is also available in this country: United States.
Switch edition